- •Hematuria II: causes and investigation
- •Hematospermia
- •Lower urinary tract symptoms (LUTS)
- •Nocturia and nocturnal polyuria
- •Flank pain
- •Urinary incontinence in adults
- •Genital symptoms
- •Abdominal examination in urological disease
- •Digital rectal examination (DRE)
- •Lumps in the groin
- •Lumps in the scrotum
- •2 Urological investigations
- •Urine examination
- •Urine cytology
- •Radiological imaging of the urinary tract
- •Uses of plain abdominal radiography (KUB X-ray—kidneys, ureters, bladder)
- •Intravenous pyelography (IVP)
- •Other urological contrast studies
- •Computed tomography (CT) and magnetic resonance imaging (MRI)
- •Radioisotope imaging
- •Post-void residual urine volume measurement
- •3 Bladder outlet obstruction
- •Regulation of prostate growth and development of benign prostatic hyperplasia (BPH)
- •Pathophysiology and causes of bladder outlet obstruction (BOO) and BPH
- •Benign prostatic obstruction (BPO): symptoms and signs
- •Diagnostic tests in men with LUTS thought to be due to BPH
- •Why do men seek treatment for their symptoms?
- •Watchful waiting for uncomplicated BPH
- •Medical management of BPH: combination therapy
- •Medical management of BPH: alternative drug therapy
- •Minimally invasive management of BPH: surgical alternatives to TURP
- •Invasive surgical alternatives to TURP
- •TURP and open prostatectomy
- •Indications for and technique of urethral catheterization
- •Indications for and technique of suprapubic catheterization
- •Management of nocturia and nocturnal polyuria
- •High-pressure chronic retention (HPCR)
- •Bladder outlet obstruction and retention in women
- •Urethral stricture disease
- •4 Incontinence
- •Causes and pathophysiology
- •Evaluation
- •Treatment of sphincter weakness incontinence: injection therapy
- •Treatment of sphincter weakness incontinence: retropubic suspension
- •Treatment of sphincter weakness incontinence: pubovaginal slings
- •Overactive bladder: conventional treatment
- •Overactive bladder: options for failed conventional therapy
- •“Mixed” incontinence
- •Post-prostatectomy incontinence
- •Incontinence in the elderly patient
- •Urinary tract infection: microbiology
- •Lower urinary tract infection
- •Recurrent urinary tract infection
- •Urinary tract infection: treatment
- •Acute pyelonephritis
- •Pyonephrosis and perinephric abscess
- •Other forms of pyelonephritis
- •Chronic pyelonephritis
- •Septicemia and urosepsis
- •Fournier gangrene
- •Epididymitis and orchitis
- •Periurethral abscess
- •Prostatitis: presentation, evaluation, and treatment
- •Other prostate infections
- •Interstitial cystitis
- •Tuberculosis
- •Parasitic infections
- •HIV in urological surgery
- •6 Urological neoplasia
- •Pathology and molecular biology
- •Prostate cancer: epidemiology and etiology
- •Prostate cancer: incidence, prevalence, and mortality
- •Prostate cancer pathology: premalignant lesions
- •Counseling before prostate cancer screening
- •Prostate cancer: clinical presentation
- •PSA and prostate cancer
- •PSA derivatives: free-to-total ratio, density, and velocity
- •Prostate cancer: transrectal ultrasonography and biopsies
- •Prostate cancer staging
- •Prostate cancer grading
- •General principles of management of localized prostate cancer
- •Management of localized prostate cancer: watchful waiting and active surveillance
- •Management of localized prostate cancer: radical prostatectomy
- •Postoperative course after radical prostatectomy
- •Prostate cancer control with radical prostatectomy
- •Management of localized prostate cancer: radical external beam radiotherapy (EBRT)
- •Management of localized prostate cancer: brachytherapy (BT)
- •Management of localized and radiorecurrent prostate cancer: cryotherapy and HIFU
- •Management of locally advanced nonmetastatic prostate cancer (T3–4 N0M0)
- •Management of advanced prostate cancer: hormone therapy I
- •Management of advanced prostate cancer: hormone therapy II
- •Management of advanced prostate cancer: hormone therapy III
- •Management of advanced prostate cancer: androgen-independent/ castration-resistant disease
- •Palliative management of prostate cancer
- •Prostate cancer: prevention; complementary and alternative therapies
- •Bladder cancer: epidemiology and etiology
- •Bladder cancer: pathology and staging
- •Bladder cancer: presentation
- •Bladder cancer: diagnosis and staging
- •Muscle-invasive bladder cancer: surgical management of localized (pT2/3a) disease
- •Muscle-invasive bladder cancer: radical and palliative radiotherapy
- •Muscle-invasive bladder cancer: management of locally advanced and metastatic disease
- •Bladder cancer: urinary diversion after cystectomy
- •Transitional cell carcinoma (UC) of the renal pelvis and ureter
- •Radiological assessment of renal masses
- •Benign renal masses
- •Renal cell carcinoma: epidemiology and etiology
- •Renal cell carcinoma: pathology, staging, and prognosis
- •Renal cell carcinoma: presentation and investigations
- •Renal cell carcinoma: active surveillance
- •Renal cell carcinoma: surgical treatment I
- •Renal cell carcinoma: surgical treatment II
- •Renal cell carcinoma: management of metastatic disease
- •Testicular cancer: epidemiology and etiology
- •Testicular cancer: clinical presentation
- •Testicular cancer: serum markers
- •Testicular cancer: pathology and staging
- •Testicular cancer: prognostic staging system for metastatic germ cell cancer
- •Testicular cancer: management of non-seminomatous germ cell tumors (NSGCT)
- •Testicular cancer: management of seminoma, IGCN, and lymphoma
- •Penile neoplasia: benign, viral-related, and premalignant lesions
- •Penile cancer: epidemiology, risk factors, and pathology
- •Squamous cell carcinoma of the penis: clinical management
- •Carcinoma of the scrotum
- •Tumors of the testicular adnexa
- •Urethral cancer
- •Wilms tumor and neuroblastoma
- •7 Miscellaneous urological diseases of the kidney
- •Cystic renal disease: simple cysts
- •Cystic renal disease: calyceal diverticulum
- •Cystic renal disease: medullary sponge kidney (MSK)
- •Acquired renal cystic disease (ARCD)
- •Autosomal dominant (adult) polycystic kidney disease (ADPKD)
- •Ureteropelvic junction (UPJ) obstruction in adults
- •Anomalies of renal ascent and fusion: horseshoe kidney, pelvic kidney, malrotation
- •Renal duplications
- •8 Stone disease
- •Kidney stones: epidemiology
- •Kidney stones: types and predisposing factors
- •Kidney stones: mechanisms of formation
- •Evaluation of the stone former
- •Kidney stones: presentation and diagnosis
- •Kidney stone treatment options: watchful waiting
- •Stone fragmentation techniques: extracorporeal lithotripsy (ESWL)
- •Intracorporeal techniques of stone fragmentation (fragmentation within the body)
- •Kidney stone treatment: percutaneous nephrolithotomy (PCNL)
- •Kidney stones: open stone surgery
- •Kidney stones: medical therapy (dissolution therapy)
- •Ureteric stones: presentation
- •Ureteric stones: diagnostic radiological imaging
- •Ureteric stones: acute management
- •Ureteric stones: indications for intervention to relieve obstruction and/or remove the stone
- •Ureteric stone treatment
- •Treatment options for ureteric stones
- •Prevention of calcium oxalate stone formation
- •Bladder stones
- •Management of ureteric stones in pregnancy
- •Hydronephrosis
- •Management of ureteric strictures (other than UPJ obstruction)
- •Pathophysiology of urinary tract obstruction
- •Ureter innervation
- •10 Trauma to the urinary tract and other urological emergencies
- •Renal trauma: clinical and radiological assessment
- •Renal trauma: treatment
- •Ureteral injuries: mechanisms and diagnosis
- •Ureteral injuries: management
- •Bladder and urethral injuries associated with pelvic fractures
- •Bladder injuries
- •Posterior urethral injuries in males and urethral injuries in females
- •Anterior urethral injuries
- •Testicular injuries
- •Penile injuries
- •Torsion of the testis and testicular appendages
- •Paraphimosis
- •Malignant ureteral obstruction
- •Spinal cord and cauda equina compression
- •11 Infertility
- •Male reproductive physiology
- •Etiology and evaluation of male infertility
- •Lab investigation of male infertility
- •Oligospermia and azoospermia
- •Varicocele
- •Treatment options for male factor infertility
- •12 Disorders of erectile function, ejaculation, and seminal vesicles
- •Physiology of erection and ejaculation
- •Impotence: evaluation
- •Impotence: treatment
- •Retrograde ejaculation
- •Peyronie’s disease
- •Priapism
- •13 Neuropathic bladder
- •Innervation of the lower urinary tract (LUT)
- •Physiology of urine storage and micturition
- •Bladder and sphincter behavior in the patient with neurological disease
- •The neuropathic lower urinary tract: clinical consequences of storage and emptying problems
- •Bladder management techniques for the neuropathic patient
- •Catheters and sheaths and the neuropathic patient
- •Management of incontinence in the neuropathic patient
- •Management of recurrent urinary tract infections (UTIs) in the neuropathic patient
- •Management of hydronephrosis in the neuropathic patient
- •Bladder dysfunction in multiple sclerosis, in Parkinson disease, after stroke, and in other neurological disease
- •Neuromodulation in lower urinary tract dysfunction
- •14 Urological problems in pregnancy
- •Physiological and anatomical changes in the urinary tract
- •Urinary tract infection (UTI)
- •Hydronephrosis
- •15 Pediatric urology
- •Embryology: urinary tract
- •Undescended testes
- •Urinary tract infection (UTI)
- •Ectopic ureter
- •Ureterocele
- •Ureteropelvic junction (UPJ) obstruction
- •Hypospadias
- •Normal sexual differentiation
- •Abnormal sexual differentiation
- •Cystic kidney disease
- •Exstrophy
- •Epispadias
- •Posterior urethral valves
- •Non-neurogenic voiding dysfunction
- •Nocturnal enuresis
- •16 Urological surgery and equipment
- •Preparation of the patient for urological surgery
- •Antibiotic prophylaxis in urological surgery
- •Complications of surgery in general: DVT and PE
- •Fluid balance and management of shock in the surgical patient
- •Patient safety in the operating room
- •Transurethral resection (TUR) syndrome
- •Catheters and drains in urological surgery
- •Guide wires
- •JJ stents
- •Lasers in urological surgery
- •Diathermy
- •Sterilization of urological equipment
- •Telescopes and light sources in urological endoscopy
- •Consent: general principles
- •Cystoscopy
- •Transurethral resection of the prostate (TURP)
- •Transurethral resection of bladder tumor (TURBT)
- •Optical urethrotomy
- •Circumcision
- •Hydrocele and epididymal cyst removal
- •Nesbit procedure
- •Vasectomy and vasovasostomy
- •Orchiectomy
- •Urological incisions
- •JJ stent insertion
- •Nephrectomy and nephroureterectomy
- •Radical prostatectomy
- •Radical cystectomy
- •Ileal conduit
- •Percutaneous nephrolithotomy (PCNL)
- •Ureteroscopes and ureteroscopy
- •Pyeloplasty
- •Laparoscopic surgery
- •Endoscopic cystolitholapaxy and (open) cystolithotomy
- •Scrotal exploration for torsion and orchiopexy
- •17 Basic science of relevance to urological practice
- •Physiology of bladder and urethra
- •Renal anatomy: renal blood flow and renal function
- •Renal physiology: regulation of water balance
- •Renal physiology: regulation of sodium and potassium excretion
- •Renal physiology: acid–base balance
- •18 Urological eponyms
- •Index
336 CHAPTER 7 Miscellaneous urological diseases of kidney
Cystic renal disease: medullary sponge kidney (MSK)
Definition
MSK is a cystic condition of the kidneys characterized by dilatation of the distal collecting ducts associated with the formation of multiple cysts and diverticula within the medulla of the kidney.
Prevalence
Prevalence is difficult to know, as MSK may be asymptomatic (diagnosed on an IVP done for other reasons or at postmortem). It is estimated to affect between 1 in 5000 and 1 in 20,000 people in the general population, and 1 in 200 in those undergoing IVP (a select population). In 75% of cases both kidneys are affected.
Pathology
The renal medulla resembles a sponge in cross-section because of dilated collecting ducts in the renal papillae and the development of numerous small cysts. This is associated with urinary stasis and the formation of small calculi within the cysts.
It has a reported familial inheritance and is associated with other malformations (hemihypertrophy).
Presentation
The majority of patients are asymptomatic. When symptoms do occur, they include ureteric colic, renal stone disease (calcium oxalate ± calcium phosphate), UTI, and hematuria (microscopic or macroscopic). Up to 50% have hypercalciuria due to renal calcium leak or increased gastrointestinal calcium absorption.
Renal function is normal, unless obstruction occurs (secondary to renal pelvis or ureteric stones).
Differential diagnosis
This includes other causes of nephrocalcinosis (deposition of calcium in the renal medulla) (e.g., TB, healed papillary necrosis).
Investigation
Intravenous pyelogram (IVP)
The characteristic radiological features of MSK, as seen on IVP, are dilatation of the distal portion of the collecting ducts with numerous associated cysts and diverticula (the dilated ducts are said to give the appearance of bristles on a brush). The collecting ducts may become filled with calcifications, giving an appearance described as a bouquet of flowers or bunches of grapes.
Biochemistry
Levels of 24-hour urinary calcium may be elevated (hypercalciuria). Detection of hypercalciuria requires further investigation to exclude other causes (i.e., raised serum parathyroid hormone levels [PTH] indicate hyperparathyroidism).
CYSTIC RENAL DISEASE: MEDULLARY SPONGE KIDNEY (MSK) 337
Treatment
Asymptomatic MSK disease requires no treatment. General measures to reduce urine calcium levels help reduce the chance of calcium stone formation (high fluid intake, vegetarian diet, low salt intake, consumption of fruit and citrus fruit juices). Thiazide diuretics may be required for hypercalciuria resistant to dietary measures designed to lower urine calcium concentration.
Intrarenal calculi are often small and, as such, may not require treatment, but if indicated this can take the form of ESWL or flexible ureteroscopy and laser treatment.
Ureteric stones are again usually small and will therefore pass spontaneously in many cases, with a period of observation. Renal function tends to remain stable in the long term.
338 CHAPTER 7 Miscellaneous urological diseases of kidney
Acquired renal cystic disease (ARCD)
Definition and epidemiology
ARCD is cystic degenerative disease of the kidney with greater than 5 cysts visualized on CT scan. By definition, this is an acquired condition, in contrast to adult polycystic kidney disease (ADPKD), which is inherited (in an autosomal dominant fashion). It is predominantly associated with chronic and end-stage renal failure (originally, it was thought to specifically affect patients on hemodialysis).
It is clinically important because it may cause pain or hematuria and is associated with the development of benign and malignant renal tumors.
Approximately one-third of patients develop ARCD after 3 years of dialysis. The male-to-female ratio is 2:1.
Pathology
Usually multiple, bilateral cysts are found mainly within the cortex of small, contracted kidneys. Cysts vary in size (average 0.5–1 cm) and are filled with a clear fluid, which may contain oxalate crystals. They usually have cuboidal and columnar epithelial linings and are in continuity with renal tubules (and thus cannot be defined as simple cysts).
Atypical cysts have a hyperplastic lining of epithelial cells, which may represent a precursor for tumor formation. Renal transplantation can cause regression of cysts in the native kidneys.
Etiology
The exact pathogenesis is unknown, but several theories have been proposed. Obstruction or ischemia of renal tubules may induce cyst formation. Renal failure may predispose to the accumulation of toxic endogenous substances or metabolites that alter the release of growth factors and result in changes in sex steroid production or cause cell proliferation (secondary to immunosuppressive effects) that results in cyst formation.
Associated disorders
There is an increased risk of benign and malignant renal tumors. The chance of developing renal cell carcinoma is 3–6 times greater than that in the general population (males > females).
ARCD may also be associated with tubulointerstitial nephritis and membranoproliferative glomerulonephritis.
Presentation
Flank pain, UTI, macroscopic hematuria, renal colic (stone disease), and hypertension can occur.
Investigation
This depends on the presenting symptoms.
-For suspected UTI—culture urine
-For hematuria—urine cytology, flexible cystoscopy, and renal ultrasound. On ultrasound the kidneys are small and hyperechoic, with multiple cysts of varying size, many of which show calcification. If the nature of the cysts cannot be determined with certainty on ultrasound, arrange for a renal CT.
ACQUIRED RENAL CYSTIC DISEASE (ARCD) 339
Treatment
Persistent macroscopic hematuria can become problematic, exacerbated by heparinization (required for hemodialysis). Options include transfer to peritoneal dialysis, renal embolization, or nephrectomy.
Infected cysts that develop into abscesses require percutaneous or surgical drainage. Radical nephrectomy is indicated for renal masses with features suspicious of malignancy.
Smaller asymptomatic masses require surveillance.